Showing results (81-90 of 9,398) with videos related to
Sort By:
Pageof 940
Clinical Pharmacology and Therapeutics|February 21, 2025
A Phenotyping Tool for Seven Cytochrome P450 Enzymes and Two Transporters: Application to Examine the Effects of Clopidogrel and GemfibrozilLaura Aurinsalo, Outi Lapatto-Reiniluoto, Mika Kurkela, et al.Clinical Pharmacology and Therapeutics|February 8, 2025
IQ Survey Results on Current Industry Practices: Part 2-Quantitative Evaluations of Immunogenicity AssessmentSusan Richards, Insa Winzenborg, Doreen Luedtke, et al.Clinical Pharmacology and Therapeutics|January 25, 2025
On the Concepts, Methods, and Use of "Probability of Success" for Drug Development Decision-Making: A Scoping ReviewAysun Cetinyurek Yavuz, Muhammad Bergas Nur Fayyad, Ce Jiang, et al.Clinical Pharmacology and Therapeutics|February 16, 2025
A Novel Two-Part Mixture Model for the Incidence and Time Course of Cytokine Release Syndrome After Elranatamab Dosing in Multiple Myeloma PatientsDonald Irby, Jennifer Hibma, Mohamed Elmeliegy, et al.Clinical Pharmacology and Therapeutics|February 4, 2025
Machine Learning for Prediction of Drug Concentrations: Application and ChallengesShuqi Huang, Qihan Xu, Guoping Yang, et al.Clinical Pharmacology and Therapeutics|February 3, 2025
CB1 Receptor Antagonist Selonabant (ANEB-001) Blocks Acute THC Effects in Healthy Volunteers: A Phase II Randomized Controlled TrialAndriy A Gorbenko, Jules A A C Heuberger, Maria Juachon, et al.Clinical Pharmacology and Therapeutics|January 24, 2025
Duration of Time Intervals for Risk Minimization Measure Effectiveness StudiesSharon C M Essink, Inge M Zomerdijk, Thomas Goedecke, et al.Clinical Pharmacology and Therapeutics|January 20, 2025
Characterization of NAT, GST, and CYP2E1 Genetic Variation in Sub-Saharan African Populations: Implications for Treatment of Tuberculosis and Other DiseasesThandeka V B Malinga, Houcemeddine Othman, Maria Paximadis, et al.Clinical Pharmacology and Therapeutics|January 18, 2025
Methodological Insights on Biomarker-Based Patient Selection: A Review of Scientific Advice Procedures at the European Medicines AgencyCynthia Huber, Joerg Zinserling, Norbert Benda, et al.Clinical Pharmacology and Therapeutics|January 7, 2025
Demonstration of Major Therapeutic Advantage From a Review of EU Conditional Marketing Authorizations in Oncology and HematologyFlorian Lasch, Joana R B Carvalho, Caroline PothetPageof 940